References
- AnanthJParameswaranSGunatilakeSBurgoyneKSidhomTNeuroleptic malignant syndrome and atypical antipsychotic drugsJ Clin Psychiatry20046546447015119907
- GambassiGCapursoSTarsitaniPLiperotiRBernabeiRFatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetineAging Clin Exp Res20061826627016804375
- StanillaJKde LeonJSimpsonGMClozapine withdrawal resulted in delirium with psychosis: a report of three casesJ Clin Psychiatry1997582522559228890
- LeeJWRobertsonSClozapine withdrawal catatonia and neuroleptic malignant syndrome: a case reportAnn Clin Psychiatry199791651699339882
- StrawnJRKeckPEJrCaroffSNNeuroleptic malignant syndromeAm J Psychiatry200716487087617541044
- KawanishiCGenetic predisposition to neuroleptic malignant syndrome: implications for antipsychotic therapyAm J Pharmacogenomics20033899512749726
- KhaldiSKornreichCChoubaniZGourevitchRAntipsychotiques atypiques et syndrome malin des neuroleptiques: brève revue de la littérature [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]Encephale200834618624 French19081460
- QureshiNAAl-HabeebTASympathoadrenal hyperactivity and neuroleptic malignant syndromeAm J Psychiatry200015731031110671434
- GabelliniASPezzoliADe MassisPCasadeiGGrilloASacquegnaTNeuroleptic malignant syndrome in an AIDS patient: clinical and pathological findingsItal J Neurol Sci1994152932957843944
- LevittAJMidhaRCravenJLNeuroleptic malignant syndrome with intravenous haloperidolCan J Psychiatry1990357892282634
- RosebushPIStewartTMazurekMFThe treatment of neuroleptic malignant syndrome: are dantrolene and bromocriptine useful adjuncts to supportive care?Br J Psychiatry19911597097121843801
- ReillyJJCroweSFLloydJHNeuroleptic toxicity syndromes: a clinical spectrumAust N Z J Psychiatry1991254995051686547
- VergheseCDeLeonJNairCSimpsonGMClozapine withdrawal effects and receptor profiles of typical and atypical neurolepticsBiol Psychiatry1996391351388717612